There are 564,000 Canadians that suffer from dementia. Over 850,000 in the UK and 5.4 million in the US live with this debilitating illness that adversely affects all those concerned. Alzheimer’s Disease is also the leading cause of death in women in the UK.

Santa Forgot

“Santa Forgot” is an animated clip about a little girl who discovers the reason she has never received a present from Father Christmas. —He has Alzheimer’s disease. As the story goes, even his elves don’t know what to do about the situation until Freya involves them in research.

“If Santa has a disease, research can find a way to fix it,” says Freya.

The story, narrated by Stephen Fry and voiced by Ciana Ayre was created to raise awareness of the illness.

Ciana’s mother, Liz, whose father died at 51 from Alzheimer’s disease, says,

“The film shows that dementia doesn’t discriminate. It affects people from so many different backgrounds from nurses and teachers to world leaders and eloquent writers. If we’re ever going to change how society views, or often ignores, dementia, we have to be a bit confrontational and challenge people’s misconceptions.”

The Power of Research

Hilary Evans, Chief Executive of Alzheimer’s Research UK, says, “We have made enormous strides against diseases like cancer and AIDS, and with the right research we can do the same for dementia. ‘Santa Forgot’ reminds us to believe in the power of research.”[the_ad id=”1277″]

Good News for 2017

Last June, the Senate Committee on Appropriations approved a bill that would boost U.S. government funding for Alzheimer’s disease to almost $1.4 billion in fiscal year 2017. Roy Blunt (R-Mo.), Chairman of the Subcommittee on the Departments of Labor, Health and Human Services, Education, and Related Agencies (Labor-HHS), and subcommittee ranking member Patty Murray (D-Wash.) co-led the bipartisan effort. The bill was approved on a 29-1 vote, receiving strong support from both Democrats and Republicans.

“There simply is no investment that promises greater return than our investment in biomedical research,” said Senator Susan Collins, (R–Maine), co-chair of the Congressional Alzheimer’s Task Force. She noted that the Advisory Council to the National Alzheimer’s Project Act has said that $2 billion a year is needed to prevent and effectively treat Alzheimer’s by 2025 (April 2014 news). “The nearly $1.4 billion in this bill represents tremendous progress toward that goal.

AntiAgingCentral.com’s Contribution

AntiAgingCentral.com supports research for Alzheimer’s Cure through donations of $1.00 for every sale made at www.AntiAgingCentral.com. Your purchase will generate a one dollar donation to the “Cure Alzheimer’s Fund”, targeting breakthrough research. You can read more about it Here

A Powerful Team of Racetams

Aniracetam and Oxiracetam are two racetams that, when used in conjunction, make a powerful team to treat the conditions of Alzheimer’s disease. Known for its novel therapeutic potential in cerebral dysfunctional disorders, Aniracetam improves several cognitive processes. It is more potent than Piracetam. Oxiracetam is one of the most popular brain supplements that also has protective properties.


0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.